Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oral idebenone is a valuable, well tolerated and safe option for improving cognitive function and other clinical symptoms in patients with Alzheimer's disease and other age-related cognitive disorders. It has also shown some promising results in delaying the progression of neurological symptoms and cardiac hypertrophy in patients with Friedreich's ataxia. © 2010 Adis Data Information BV. All rights reserved.

Original publication

DOI

10.2165/11203510-000000000-00000

Type

Journal article

Journal

Drugs and Therapy Perspectives

Publication Date

21/01/2010

Volume

26

Pages

1 - 5